quinacrine has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhuri, T; Das, D; Kundu, CN; Mohapatra, P; Preet, R; Satapathy, SR; Wyatt, MD | 1 |
| Ding, C; Ge, X; Jiang, J; Li, S; Li, Y; Qiao, Y; Wang, D; Wang, M; Wang, Y; Zheng, X | 1 |
2 other study(ies) available for quinacrine and cyclin d1
| Article | Year |
|---|---|
Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Topics: Adenomatous Polyposis Coli Protein; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Blotting, Western; Breast Neoplasms; Carotenoids; Cell Cycle; Cell Proliferation; Comet Assay; Cyclin D1; Drug Synergism; Etoposide; Female; Flow Cytometry; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lycopene; Promoter Regions, Genetic; Quinacrine; RNA, Small Interfering; Signal Transduction; T Cell Transcription Factor 1; TCF Transcription Factors; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Wnt Proteins | 2013 |
Combination of niclosamide and quinacrine inactivates Akt/HK2/Cyclin D1 axis mediated by glucose deprivation towards the inhibition of melanoma cell proliferation.
Topics: Cell Line, Tumor; Cell Proliferation; Cyclin D1; Glucose; Humans; Melanoma; Niclosamide; Proto-Oncogene Proteins c-akt; Quinacrine; Signal Transduction | 2023 |